Study on Ivermectin and Cancer Treatment

We had 200 cancer patients that were prescribed ivermectin and membendazole compounded tablets,

and after six months, 84.4% of them declared either remission,

tumor regression, tumor shrinkage, or cancer stabilization.

The tumor stopped growing.

84%. And now it is officially peer-reviewed

and in a major cancer journal,

published by the International Institute of Cancer. Institute of Anticancer Research.

They've been around since the 90s and so now it is going mainstream.

So this is absolutely huge and it's the largest human study

to date showing that ivermectin and membenazole have an extremely large clinical benefit signal.